Argus
•
Apr 08, 2026
HAE: Raising target price to $66.00
Summary
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection,
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Cardinal Health, Inc.
Apr 30, 2026
•
CAH
Analyst Report: Cardinal Health, Inc.
Apr 30, 2026
•
CAH
Daily – Vickers Top Buyers & Sellers for 04/29/2026
Apr 29, 2026
•
BLK, WULF, VMI, ABT, MSCI, LW, CHTR, NBP, ELF
MMSI: Lowering target price to $73.00
Apr 29, 2026
•
MMSI
GKOS: Lowering target price to $126.00
Apr 29, 2026
•
GKOS
